An alternatively spliced form of the nerve growth factor receptor TrkA confers an enhanced response to neurotrophin 3 - PubMed (original) (raw)

An alternatively spliced form of the nerve growth factor receptor TrkA confers an enhanced response to neurotrophin 3

D O Clary et al. Proc Natl Acad Sci U S A. 1994.

Abstract

TrkA, a member of the receptor tyrosine kinase family, binds nerve growth factor (NGF) and subsequently activates intracellular signaling pathways. Previous studies have found variable and weak interaction of the TrkA receptor with neurotrophin 3 (NT-3), another member of the NGF family. TrkA is expressed in two splice forms, differing in the presence of an 18-bp exon in the extracellular domain. The biological responses of each isoform of the TrkA receptor were tested after transfection into the cell line PC12nnr5, a variant of PC12 cells lacking functional TrkA protein. NGF was found to activate each form of the receptor comparably. However, the TrkA isoform containing the variable exon showed significantly higher activation by NT-3, which was detected by stimulation of TrkA autophosphorylation, induction of ZIF268 transcription, and cellular differentiation. Function-perturbing antibodies to the p75 low-affinity NGF receptor potentiated the NT-3 responses of both forms of TrkA in the transfected PC12nnr5 cell lines, suggesting that the low-affinity NGF receptor suppresses the ability of TrkA to respond to NT-3.

PubMed Disclaimer

Cited by

Differential roles of Trk and p75 neurotrophin receptors in tumorigenesis and chemoresistance ex vivo and in vivo.
Bassili M, Birman E, Schor NF, Saragovi HU. Bassili M, et al. Cancer Chemother Pharmacol. 2010 May;65(6):1047-56. doi: 10.1007/s00280-009-1110-x. Epub 2009 Aug 22. Cancer Chemother Pharmacol. 2010. PMID: 19701634 Free PMC article.
Structural basis for the transmembrane signaling and antidepressant-induced activation of the receptor tyrosine kinase TrkB.
Kot EF, Goncharuk SA, Franco ML, McKenzie DM, Arseniev AS, Benito-Martínez A, Costa M, Cattaneo A, Hristova K, Vilar M, Mineev KS. Kot EF, et al. Nat Commun. 2024 Oct 29;15(1):9316. doi: 10.1038/s41467-024-53710-7. Nat Commun. 2024. PMID: 39472452 Free PMC article.
Mechanisms of disease in hereditary sensory and autonomic neuropathies.
Rotthier A, Baets J, Timmerman V, Janssens K. Rotthier A, et al. Nat Rev Neurol. 2012 Jan 24;8(2):73-85. doi: 10.1038/nrneurol.2011.227. Nat Rev Neurol. 2012. PMID: 22270030 Review.
Neurotrophin-3 as an essential signal for the developing nervous system.
Chalazonitis A. Chalazonitis A. Mol Neurobiol. 1996 Feb;12(1):39-53. doi: 10.1007/BF02740746. Mol Neurobiol. 1996. PMID: 8732539 Review.
Mice lacking brain-derived neurotrophic factor exhibit visceral sensory neuron losses distinct from mice lacking NT4 and display a severe developmental deficit in control of breathing.
Erickson JT, Conover JC, Borday V, Champagnat J, Barbacid M, Yancopoulos G, Katz DM. Erickson JT, et al. J Neurosci. 1996 Sep 1;16(17):5361-71. doi: 10.1523/JNEUROSCI.16-17-05361.1996. J Neurosci. 1996. PMID: 8757249 Free PMC article.

References

1. Neuron. 1992 Sep;9(3):465-78 - PubMed
1. Neuron. 1992 Sep;9(3):449-63 - PubMed
1. Neuron. 1992 Oct;9(4):583-93 - PubMed
1. Neuron. 1992 Nov;9(5):883-96 - PubMed
1. Mol Cell Biol. 1993 Jan;13(1):105-13 - PubMed

An alternatively spliced form of the nerve growth factor receptor TrkA confers an enhanced response to neurotrophin 3 - PubMed (original) (raw)